Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Feb / Cognitive Impairment and Glaucoma
Glaucoma Research & Innovations Neuro-ophthalmology

Cognitive Impairment and Glaucoma

Journal of Glaucoma study links cognitive impairment and elevated cortisol levels to primary open-angle glaucoma

By The Ophthalmologist 2/19/2025 1 min read

Share

Original images sourced from: AdobeStock.com

A new case-control study has revealed that individuals with primary open-angle glaucoma (POAG) can exhibit significant cognitive impairments when compared to their age- and sex-matched healthy counterparts. The study, undertaken by researchers in New Delhi, India, suggests – as previously reported in The British Journal of Ophthalmology, Aging Clinical and Experimental Research and other journals – that glaucoma not only affects vision but also impacts cognitive function.

In the Journal of Glaucoma study, the researchers analyzed 70 POAG patients and 70 healthy controls, conducting comprehensive ophthalmological evaluations and serum cortisol measurements on the cohort. A wide range of cognitive function tests were also undertaken by the participants, including the Trail Making Test (TMT), a neuropsychological test on attention and memory; the Post-Graduate Institute Memory Scale (PGIMS), for assessing non-verbal and verbal memory; the Addenbrooke Cognitive Examination (ACE-III), an exam measuring verbal fluency, visuospatial skills, memory and language; and the Wisconsin Card Sorting Test (WCST), a task designed for examining non-verbal executive functions which is commonly used to identify frontal lobe problems.

The findings reveal that, in terms of cognitive impairment, POAG patients displayed significantly lower scores on the ACE-III and PGIMS, indicating deficits in their memory, attention, and executive functions. In terms of processing speed, POAG patients took a significantly longer amount of time completing TMT, reflecting impaired working memory and attention, while their performance in the WCST exhibited significantly worse scores, indicating difficulties with decision-making and inhibitory control. POAG patients were also found to have higher serum cortisol levels than the healthy controls. Because cortisol is directly linked to neurodegeneration, the authors suggest that relaxation techniques, such as meditation, might be useful in delaying the cognitive decline witnessed in glaucoma patients.

In light of these findings, earlier cognitive screening in POAG patients is recommended, with suggestions that implementing a more holistic perspective to the disease could help clinicians to create more personalized and effective strategies for treatment.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: